25
Defining and Reducing the Impact of Pediatric Infections
Thursday, October 9, 2014: 8:30 AM-10:00 AM
Room: The Pennsylvania Convention Center: 111-AB
Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Health care workers, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Medical students and residents, Members-in-training, Microbiologists, Nurses, Pharmacists, Public health practitioners, Scientists, Vaccinologists
Tracks: Adult ID, Epidemiology and Infection Control, Global ID, Investigative ID, Pediatric ID
Moderators:
Tina Tan, MD, FIDSA, Northwestern University Feinberg School of Medicine
and
Mark Abzug, MD, University of Colorado School of Medicine
Presentations:
8:30 AM
Continued Decline in Invasive Pneumococcal Infections in Children Among 8 Children's Hospitals in the United States 2011 to 2013
Sheldon L. Kaplan, MD, FIDSA
;
William J. Barson, MD
;
Philana Ling Lin, MD
;
Jose Romero, MD
;
John S. Bradley, MD, FIDSA
;
Tina Tan, MD, FIDSA
;
Jill Hoffman, MD
;
Laurence B. Givner, MD
;
Kristina G. Hulten, PhD
;
Edward Mason, PhD
8:45 AM
Pneumococcal Meningitis among 8 Children’s Hospitals in the United States in the 13-valent Pneumococcal Conjugate Vaccine Era
Liset Olarte, MD
;
William J. Barson, MD
;
Philana Ling Lin, MD
;
Jose Romero, MD
;
Tina Tan, MD, FIDSA
;
Laurence B. Givner, MD
;
John S. Bradley, MD, FIDSA
;
Jill Hoffman, MD
;
Kristina G. Hulten, PhD
;
Edward Mason, PhD
;
Sheldon L. Kaplan, MD, FIDSA
9:00 AM
Prevention of Antimicrobial Resistant Infection Among Children Aged <5 Years with the 13-valent Pneumococcal Conjugate Vaccine — Selected U.S. Areas, 2005–2013
Sara Tomczyk
;
James Jorgensen, PhD
;
Ruth Lynfield, MD
;
William Schaffner, MD
;
Deborah Aragon, MSPH
;
Lee Harrison, MD
;
Megin Nichols, DVM, MPH, DACVPM
;
Susan Petit, MPH
;
Ann Thomas, MD, MPH
;
Arthur Reingold, MD
;
Monica M. Farley, MD
;
Shelley M. Zansky, PhD
;
Bernard Beall, PhD
;
Lesley Mcgee, PhD
;
Lindsay Kim, MD, MPH
9:15 AM
A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates with Enterovirus Sepsis
Mark Abzug, MD
;
Marian Michaels, MD
;
Ellen Wald, MD
;
Richard Jacobs, MD
;
Jose R. Romero, MD
;
Pablo J. Sanchez, MD, FIDSA
;
Gregory Wilson, MD
;
Paul Krogstad, MD
;
Gregory Storch, MD, FIDSA
;
Robert Lawrence, MD
;
Mark Shelton, MD
;
April Palmer, MD
;
Joan Robinson, MD
;
Penelope H. Dennehy, MD, FIDSA
;
Sunil Sood, MD
;
Gretchen Cloud, MS
;
Penelope Jester, MSN BSN
;
Edward Acosta, PharmD
;
Richard Whitley, MD, FIDSA
;
David W. Kimberlin, MD, FIDSA
9:30 AM
National Estimates of Pediatric Infectious Disease Hospitalizations from 1997-2009: An Analysis of the Kids’ Inpatient Database
Chris Stockmann, MSc
;
Adam L. Hersh, MD, PhD
;
Kwabena Ampofo, MD
;
Carrie L. Byington, MD
;
Catherine Sherwin, PhD
;
Michael Spigarelli, MD, PhD
;
Andrew Pavia, MD, FIDSA, FSHEA
9:45 AM
Population-based Incidence of Childhood Pneumonia Associated with Viral Infections in a Tropical Developing Country
Fiona Havers, MD, MHS
;
Alicia M. Fry, MD, MPH
;
Doli Goswami, MBBS, MSc
;
Kamrun Nahar, MBBS, MPH
;
Amina Tahia Sharmeen, MBBS, MPH
;
Mustafizur Rahman, PhD
;
W. Abdullah Brooks, MD, MPH
CME Credits:
ACPE Credits:
ACPE Number:
Disclosures:
T. Tan,
Merck Labs: Grant Investigator and Scientific Advisor, Research grant
Sanofi Pasteur: Consultant, Grant Investigator and Scientific Advisor, Educational grant, Research grant and Speaker honorarium
GSK: Consultant and Scientific Advisor, Consulting fee
Pfizer Wyeth: Scientific Advisor, Consulting fee
Biota: Scientific Advisor, Consulting fee
M. Abzug,
None
